These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38526287)

  • 1. OSMR is a potential driver of inflammation in amyotrophic lateral sclerosis.
    Chen W; Jiang S; Li S; Li C; Xu R
    Neural Regen Res; 2024 Nov; 19(11):2513-2521. PubMed ID: 38526287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study.
    He L; Zhou Q; Xiu C; Shao Y; Shen D; Meng H; Le W; Chen S
    Neural Regen Res; 2024 Aug; 19(8):1842-1848. PubMed ID: 38103252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 cytoplasmic inclusion formation is disrupted in
    Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin LS; Li L; Glass JD
    Brain Commun; 2019; 1(1):fcz014. PubMed ID: 31633109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis.
    Ruf WP; Boros M; Freischmidt A; Brenner D; Grozdanov V; de Meirelles J; Meyer T; Grehl T; Petri S; Grosskreutz J; Weyen U; Guenther R; Regensburger M; Hagenacker T; Koch JC; Emmer A; Roediger A; Steinbach R; Wolf J; Weishaupt JH; Lingor P; Deschauer M; Cordts I; Klopstock T; Reilich P; Schoeberl F; Schrank B; Zeller D; Hermann A; Knehr A; Günther K; Dorst J; Schuster J; Siebert R; Ludolph AC; Müller K
    Brain Commun; 2023; 5(3):fcad152. PubMed ID: 37223130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
    Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
    Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis.
    Wong JK; Roselle AK; Shue TM; Shimshak SJE; Beaty JM; Celestin NM; Gao I; Griffin RP; Cudkowicz ME; Sadiq SA
    Brain Commun; 2022; 4(4):fcac207. PubMed ID: 36043141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation.
    Kotni MK; Zhao M; Wei DQ
    Orphanet J Rare Dis; 2016 Nov; 11(1):148. PubMed ID: 27814735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.
    Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS
    Brain; 2022 Jun; 145(5):1598-1609. PubMed ID: 35202463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis.
    Catanese A; Rajkumar S; Sommer D; Masrori P; Hersmus N; Van Damme P; Witzel S; Ludolph A; Ho R; Boeckers TM; Mulaw M
    Brain; 2023 Sep; 146(9):3770-3782. PubMed ID: 36883643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
    Olsen CG; Busk ØL; Aanjesen TN; Alstadhaug KB; Bjørnå IK; Braathen GJ; Breivik KL; Demic N; Flemmen HØ; Hallerstig E; HogenEsch I; Holla ØL; Jøntvedt AB; Kampman MT; Kleveland G; Kvernmo HB; Ljøstad U; Maniaol A; Morsund ÅH; Nakken O; Novy C; Rekand T; Schlüter K; Schüler S; Tveten K; Tysnes OB; Holmøy T; Høyer H
    Neuroepidemiology; 2022; 56(4):271-282. PubMed ID: 35576897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
    Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
    Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
    Sattler R; Traynor BJ; Robertson J; Van Den Bosch L; Barmada SJ; Svendsen CN; Disney MD; Gendron TF; Wong PC; Turner MR; Boxer A; Babu S; Benatar M; Kurnellas M; Rohrer JD; Donnelly CJ; Bustos LM; Van Keuren-Jensen K; Dacks PA; Sabbagh MN;
    Neurol Ther; 2023 Dec; 12(6):1821-1843. PubMed ID: 37847372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis.
    Gregory JM; McDade K; Livesey MR; Croy I; Marion de Proce S; Aitman T; Chandran S; Smith C
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):441-457. PubMed ID: 31925813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
    JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts.
    Rifai OM; O'Shaughnessy J; Dando OR; Munro AF; Sewell MDE; Abrahams S; Waldron FM; Sibley CR; Gregory JM
    Brain; 2023 Dec; 146(12):5124-5138. PubMed ID: 37450566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of SOD1 and C9orf72 mutations in patients with amyotrophic lateral sclerosis in Antioquia, Colombia.
    Jaramillo J; Solano JM; Aristizábal A; Martínez J
    Biomedica; 2022 Dec; 42(4):623-632. PubMed ID: 36511680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced penetrance of gene variants causing amyotrophic lateral sclerosis.
    Douglas AGL; Baralle D
    J Med Genet; 2024 Feb; 61(3):294-297. PubMed ID: 38123999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.
    Allen SP; Hall B; Woof R; Francis L; Gatto N; Shaw AC; Myszczynska M; Hemingway J; Coldicott I; Willcock A; Job L; Hughes RM; Boschian C; Bayatti N; Heath PR; Bandmann O; Mortiboys H; Ferraiuolo L; Shaw PJ
    Brain; 2019 Dec; 142(12):3771-3790. PubMed ID: 31647549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK.
    Morgan S; Shatunov A; Sproviero W; Jones AR; Shoai M; Hughes D; Al Khleifat A; Malaspina A; Morrison KE; Shaw PJ; Shaw CE; Sidle K; Orrell RW; Fratta P; Hardy J; Pittman A; Al-Chalabi A
    Brain; 2017 Jun; 140(6):1611-1618. PubMed ID: 28430856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.